{
    "clinical_study": {
        "@rank": "11548", 
        "arm_group": [
            {
                "arm_group_label": "Cohort 1: HER2 positive breast cancer", 
                "description": "Female patients with newly diagnosed (including metastatic) HER2 positive breast cancer."
            }, 
            {
                "arm_group_label": "Cohort 2: HER2 negative breast cancer", 
                "description": "Female patients with newly diagnosed HER2 negative breast cancer"
            }
        ], 
        "brief_summary": {
            "textblock": "Primary Objective:\n\n      (i) To identify panels of RNAs and proteins predictive of response to HER2 targeted agents,\n      considering clinical responses. (ii) To investigate associations between presence vs.\n      absence (or relative levels) of identified extracellular (EC) RNAs/proteins and patients'\n      clinicopathological characteristics, including age at diagnosis, time to progression and\n      overall survival, as well as correlations with serum protein biomarkers routinely analysed\n      for these patients. (iii) To compare HER2 positive samples versus HER2 negative samples for\n      the existence of RNAs/proteins identified in (i) and (ii).\n\n      Secondary Objective:\n\n      To develop a predictive model for use in the HER2 positive population based on the most\n      accurate and sensitive combination of the identified biomarkers."
        }, 
        "brief_title": "Exosomal and Free Extracellular RNAs and Proteins as Predictive. ICORG 10-15, V2", 
        "condition": [
            "Breast Cancer", 
            "HER2 Positive Breast Cancer", 
            "HER2 Negative Breast Cancer"
        ], 
        "condition_browse": {
            "mesh_term": "Breast Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "This is a translational pilot study, involving two patient cohorts, designed to identify\n      predictive biomarkers for HER2 targeted therapy, which will be validated in a larger future\n      study.\n\n      Cohort 1: 300 newly diagnosed (including metastatic) HER2 positive breast cancer patients.\n      Cohort 2: 30 newly diagnosed HER2 negative breast cancer patients.\n\n      Blood specimens will be taken:\n\n        -  before starting treatment (cohort 1 and 2)\n\n        -  after receiving chemotherapy and before starting HER2 targeted treatment (if\n           applicable) (cohort 1)\n\n        -  within one month following 1st treatment of HER2 targeted treatment (cohort 1)\n\n        -  approximately every 3 months (coinciding with formal disease assessment) while on HER2\n           targeted treatment for a maximum of 5 years (cohort 1)\n\n      Blood will be processed to serum, which will be analysed for RNA and protein biomarkers."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Patient with a newly diagnosed (including metastatic) HER2 positive breast cancer,\n             who is to commence HER2 targeted treatment.\n\n             OR\n\n             - Patient with a newly diagnosed HER2 negative breast cancer, who is to commence any\n             type of treatment.\n\n          2. Patient must be female and aged 18 years or over.\n\n          3. Patient must provide written informed consent.\n\n        Exclusion Criteria:\n\n        1. Patients who do not fulfil the inclusion criteria mentioned above"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "-  HER2 positive breast cancer:Female patients with newly diagnosed (including\n             metastatic) HER2 positive breast cancer.\n\n          -  HER2 negative breast cancer:Female patients with newly diagnosed HER2 negative breast\n             cancer."
            }
        }, 
        "enrollment": {
            "#text": "330", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 23, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01840306", 
            "org_study_id": "ICORG 10-15"
        }, 
        "intervention": {
            "arm_group_label": [
                "Cohort 1: HER2 positive breast cancer", 
                "Cohort 2: HER2 negative breast cancer"
            ], 
            "intervention_name": "Biomarker Analysis", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 23, 2014", 
        "location": [
            {
                "contact": {
                    "last_name": "Contact Person", 
                    "phone": "021-4546400"
                }, 
                "facility": {
                    "address": {
                        "city": "Cork", 
                        "country": "Ireland"
                    }, 
                    "name": "Cork University Hospital"
                }, 
                "investigator": {
                    "last_name": "Seamus O'Reilly, Dr", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Contact Person", 
                    "phone": "021-4542807"
                }, 
                "facility": {
                    "address": {
                        "city": "Cork", 
                        "country": "Ireland"
                    }, 
                    "name": "Bon Secours Hospital"
                }, 
                "investigator": {
                    "last_name": "Brian Bird, Dr", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Contact Person", 
                    "phone": "01-8093000"
                }, 
                "facility": {
                    "address": {
                        "city": "Dublin", 
                        "country": "Ireland"
                    }, 
                    "name": "Beaumont Hospital"
                }, 
                "investigator": {
                    "last_name": "Oscar Breathnach, Dr", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Contact Person", 
                    "phone": "01-2214000"
                }, 
                "facility": {
                    "address": {
                        "city": "Dublin", 
                        "country": "Ireland"
                    }, 
                    "name": "St Vincent's University Hospital"
                }, 
                "investigator": {
                    "last_name": "John Crown, Prof", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Contact Person", 
                    "phone": "01-4103000"
                }, 
                "facility": {
                    "address": {
                        "city": "Dublin", 
                        "country": "Ireland"
                    }, 
                    "name": "St James's Hospital"
                }, 
                "investigator": {
                    "last_name": "John Kennedy, Dr", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Contact Person", 
                    "phone": "01-4142000"
                }, 
                "facility": {
                    "address": {
                        "city": "Dublin", 
                        "country": "Ireland"
                    }, 
                    "name": "The Adelaide & Meath Hospital, Dublin Incorporating the National Children's Hospital"
                }, 
                "investigator": {
                    "last_name": "Janice Walshe, Dr", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Contact Person", 
                    "phone": "071-9171111"
                }, 
                "facility": {
                    "address": {
                        "city": "Sligo", 
                        "country": "Ireland"
                    }, 
                    "name": "Sligo General Hospital"
                }, 
                "investigator": {
                    "last_name": "Michael Martin, Dr", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Ireland"
        }, 
        "number_of_groups": "2", 
        "official_title": "Exosomal and Free Extracellular RNAs and Proteins as Predictive Biomarkers for HER2 Therapies in Breast Cancer", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Ireland: Health Information and Quality Authority", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2020", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Identification of EC RNAs/proteins in sera from cancer patients, which correlate with their response to treatment", 
            "measure": "Identification of Extra Cellular RNAs/proteins in sera from cancer patients", 
            "safety_issue": "No", 
            "time_frame": "7 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01840306"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "ICORG- All Ireland Cooperative Oncology Research Group", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "ICORG- All Ireland Cooperative Oncology Research Group", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "January 2014"
    }
}